#$%^&*AU2020217386A120200903.pdf#####1003127522 ABSTRACT: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide 5 having a certain particle size distribution for the manufacture of a pharmaceutical composition.